SE371190B - - Google Patents

Info

Publication number
SE371190B
SE371190B SE7203905A SE390572A SE371190B SE 371190 B SE371190 B SE 371190B SE 7203905 A SE7203905 A SE 7203905A SE 390572 A SE390572 A SE 390572A SE 371190 B SE371190 B SE 371190B
Authority
SE
Sweden
Application number
SE7203905A
Inventor
B Goeransson
N Joensson
F Merenyi
Original Assignee
Kabi Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kabi Ab filed Critical Kabi Ab
Priority to SE7203905A priority Critical patent/SE371190B/xx
Priority to FI817/73A priority patent/FI57253C/fi
Priority to CA166,508A priority patent/CA1032165A/en
Priority to US05/343,129 priority patent/US4172093A/en
Priority to AT255373A priority patent/AT329045B/de
Priority to DK156173AA priority patent/DK138598B/da
Priority to AU53651/73A priority patent/AU473728B2/en
Priority to JP48032772A priority patent/JPS599540B2/ja
Priority to DE2314636A priority patent/DE2314636C2/de
Priority to NO1209/73A priority patent/NO138628C/no
Priority to FR7310580A priority patent/FR2177929B1/fr
Priority to CH428173A priority patent/CH621110A5/de
Priority to GB1422473A priority patent/GB1421208A/en
Publication of SE371190B publication Critical patent/SE371190B/xx
Priority to AT76775A priority patent/AT333743B/de
Priority to AT76875A priority patent/AT333744B/de
Priority to CH32779A priority patent/CH626045A5/de
Priority to CH32579A priority patent/CH626044A5/de
Priority to CH32679A priority patent/CH622769A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
    • C07D295/03—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/45—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by at least one doubly—bound oxygen atom, not being part of a —CHO group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/657—Unsaturated compounds containing a keto groups being part of a ring containing six-membered aromatic rings
    • C07C49/665—Unsaturated compounds containing a keto groups being part of a ring containing six-membered aromatic rings a keto group being part of a condensed ring system
    • C07C49/675—Unsaturated compounds containing a keto groups being part of a ring containing six-membered aromatic rings a keto group being part of a condensed ring system having three rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/687—Unsaturated compounds containing a keto groups being part of a ring containing halogen
    • C07C49/697—Unsaturated compounds containing a keto groups being part of a ring containing halogen containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/747—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/753—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/46—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings and other rings, e.g. cyclohexylphenylacetic acid
    • C07C57/50—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings and other rings, e.g. cyclohexylphenylacetic acid containing condensed ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/52—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen
    • C07C57/62—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings and other rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Anesthesiology (AREA)
  • Psychiatry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
SE7203905A 1872-03-24 1972-03-24 SE371190B (sv)

Priority Applications (18)

Application Number Priority Date Filing Date Title
SE7203905A SE371190B (sv) 1972-03-24 1972-03-24
FI817/73A FI57253C (fi) 1972-03-24 1973-03-16 Foerfarande foer framstaellning av nya farmakodynamiskt aktiva basiskt substituerade indanderivat
CA166,508A CA1032165A (en) 1972-03-24 1973-03-20 Pharmacodynamically active indan derivatives
US05/343,129 US4172093A (en) 1872-03-24 1973-03-20 Pharmacodynamically active indan derivatives
AT255373A AT329045B (de) 1972-03-24 1973-03-22 Verfahren zur herstellung von neuen, basisch substituierten indanderivaten
DK156173AA DK138598B (da) 1972-03-24 1973-03-22 Analogifremgangsmåde til fremstilling af farmakodynamisk aktive, basisk substituerede indanderivater.
AU53651/73A AU473728B2 (en) 1972-03-24 1973-03-22 New, pharmacodyanmicall active indan derivatives
NO1209/73A NO138628C (no) 1972-03-24 1973-03-23 Analogifremgangsmaate for fremstilling av farmakodynamisk aktive, basisk substituerte indanderivater
DE2314636A DE2314636C2 (de) 1972-03-24 1973-03-23 Indanderivate, deren Herstellung und diese enthaltende pharmazeutische Mittel
JP48032772A JPS599540B2 (ja) 1972-03-24 1973-03-23 薬剤としての有効な新活性インダン誘導体の製法
FR7310580A FR2177929B1 (sv) 1972-03-24 1973-03-23
CH428173A CH621110A5 (sv) 1972-03-24 1973-03-23
GB1422473A GB1421208A (en) 1972-03-24 1973-03-23 Pharmacodynamically active indane derivatives
AT76775A AT333743B (de) 1972-03-24 1975-02-03 Verfahren zur herstellung von neuen, basisch substituierten indanderivaten
AT76875A AT333744B (de) 1972-03-24 1975-02-03 Verfahren zur herstellung von neuen, basisch substituierten indenderivaten
CH32779A CH626045A5 (sv) 1972-03-24 1979-01-12
CH32579A CH626044A5 (sv) 1972-03-24 1979-01-12
CH32679A CH622769A5 (sv) 1972-03-24 1979-01-12

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7203905A SE371190B (sv) 1972-03-24 1972-03-24

Publications (1)

Publication Number Publication Date
SE371190B true SE371190B (sv) 1974-11-11

Family

ID=20263107

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7203905A SE371190B (sv) 1872-03-24 1972-03-24

Country Status (12)

Country Link
US (1) US4172093A (sv)
JP (1) JPS599540B2 (sv)
AT (1) AT329045B (sv)
CA (1) CA1032165A (sv)
CH (4) CH621110A5 (sv)
DE (1) DE2314636C2 (sv)
DK (1) DK138598B (sv)
FI (1) FI57253C (sv)
FR (1) FR2177929B1 (sv)
GB (1) GB1421208A (sv)
NO (1) NO138628C (sv)
SE (1) SE371190B (sv)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2861735D1 (en) * 1977-08-05 1982-05-27 Kabi Ab Geminally disubstituted indene derivatives, processes for their preparation and pharmaceutical compositions containing them
CH641147A5 (de) * 1979-01-17 1984-02-15 Sandoz Ag 3-amino-2-hydroxypropoxyaryl-derivat, seine herstellung und dieses enthaltende heilmittel.
CH647235A5 (de) * 1980-02-13 1985-01-15 Sandoz Ag 4-(2,2-dialkylindan-1-yliden)piperidin derivate, ihre herstellung und verwendung.
IL103106A (en) * 1991-09-25 1998-06-15 Sanofi Elf Sites of tynocyclopentanone oximes, their preparation and pharmaceutical preparations containing them
GB9309621D0 (en) * 1993-05-11 1993-06-23 Wellcome Found Amide derivatives and their therapeutic use
US5877218A (en) * 1994-01-10 1999-03-02 Teva Pharmaceutical Industries, Ltd. Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives
MY113062A (en) * 1994-05-10 2001-11-30 The Wellcome Foundation Ltd Amide derivatives and their therapeutic use
DE69732984T2 (de) 1996-12-18 2006-02-16 Teva Pharmaceutical Industries Ltd. Aminoindanderivate
US6124284A (en) * 1998-07-16 2000-09-26 Glaxo Wellcome Inc. Bicyclic amide derivatives and their use as muscle relaxants
US6737547B1 (en) 1998-12-31 2004-05-18 Teva Pharmaceutical Industries, Ltd. Compositions containing and methods of using N-acyl-1H-aminoindenes
US20040010038A1 (en) * 2002-02-27 2004-01-15 Eran Blaugrund Propargylamino indan derivatives and propargylamino tetralin derivatives as brain-selective MAO inhibitors
GB0328906D0 (en) 2003-12-12 2004-01-14 Syngenta Participations Ag Chemical compounds
US20070135518A1 (en) * 2005-12-09 2007-06-14 Marta Weinstock-Rosin Use of low-dose ladostigil for neuroprotection
BRPI0620659A2 (pt) * 2005-12-09 2017-10-31 Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd método para a prevenção do aparecimento de sintomas de uma doença neurodegenerativa em um indivíduo predisposto à doença neurodegenerativa, método de redução de stress oxidante no cérebro de um indivíduo afligido com stress oxidante, método de tratamento de um indivíduo afligido com a degeneração cognitiva suave e composição farmacêutica
TW200744576A (en) * 2006-02-24 2007-12-16 Teva Pharma Propargylated aminoindans, processes for preparation, and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1007323B (de) * 1956-04-13 1957-05-02 Schering Ag Verfahren zur Herstellung von 1-Aminoindanen mit coronargefaesserweiternder Wirkung
US3308157A (en) * 1964-08-07 1967-03-07 Colgate Palmolive Co N-(benzocyclobutene-1-loweralkyl)-carboxylic acid amides
US3360435A (en) * 1964-09-15 1967-12-26 Mead Johnson & Co Treatment of depressed states
US3553093A (en) * 1965-03-19 1971-01-05 Xerox Corp Color photoelectrophoretic imaging process
GB1139135A (en) * 1965-10-01 1969-01-08 Kefalas As Aminoalkyl-substituted indanes and pharmaceutical compositions containing them
US3657440A (en) * 1968-04-23 1972-04-18 Ciba Geigy Corp Aminoalkyl-spirocycloalkanes as analgetic agents
CH554310A (de) * 1968-04-23 1974-09-30 Ciba Geigy Ag Verfahren zur herstellung von neuen 1-aminoalkylidenbenzcycloalkan-2-spirocycloaliphatischen verbindungen.

Also Published As

Publication number Publication date
DE2314636C2 (de) 1986-09-11
CH622769A5 (sv) 1981-04-30
FR2177929A1 (sv) 1973-11-09
GB1421208A (en) 1976-01-14
CH621110A5 (sv) 1981-01-15
CH626045A5 (sv) 1981-10-30
JPS495957A (sv) 1974-01-19
FR2177929B1 (sv) 1976-10-22
NO138628C (no) 1978-10-11
CH626044A5 (sv) 1981-10-30
DK138598C (sv) 1979-03-26
US4172093A (en) 1979-10-23
FI57253C (fi) 1980-07-10
NO138628B (no) 1978-07-03
DE2314636A1 (de) 1973-10-04
AT329045B (de) 1976-04-26
FI57253B (fi) 1980-03-31
ATA255373A (de) 1975-07-15
DK138598B (da) 1978-10-02
CA1032165A (en) 1978-05-30
JPS599540B2 (ja) 1984-03-03
AU5365173A (en) 1974-09-26

Similar Documents

Publication Publication Date Title
JPS4912964A (sv)
FR2177929B1 (sv)
FR2207215A1 (sv)
FR2179101B1 (sv)
JPS5724499B2 (sv)
JPS5322904Y2 (sv)
JPS492601U (sv)
JPS4922774U (sv)
JPS5143654B2 (sv)
JPS49133053A (sv)
JPS4947071U (sv)
JPS493358A (sv)
JPS4953267A (sv)
JPS5127520Y1 (sv)
JPS4981614U (sv)
JPS4997350U (sv)
JPS4978795A (sv)
JPS4898340U (sv)
JPS4952766U (sv)
JPS4951877U (sv)
CH591552A5 (sv)
CH587276A5 (sv)
CH441173A4 (sv)
CH578290A5 (sv)
CH580150A5 (sv)